MDS: Treatment paradigms are changing
hemato-oncology, Tracking Studies, Syndicated Studies, Oncology
MyeloDysplastic Syndromes: our syndicated research will tell you why - and how - treatment...
Posts about
Tracking Studies
DLBCL Patient Insights in the US and EU5
hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies
When working on a new or existing brand within the DLBCL market it's important to have up to date...
DLBCL Treatment Performance in EU5 and US
hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies
The DLBCL market is undergoing a period of change, and the relative performance of the various...
DLBCL Market Overview
hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies, Oncology
Following the release of our latest ebook, this is the first blog post in this series focusing on...
New AplusA eBook Covers the DLBCL Market
AplusA News, hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies, Oncology
Introducing the latest eBook in AplusA's Hemato-Oncology series
Enhancing Traditional Research Methods with Social Media Listening
How do social media intelligence insights enhance your capability to make data-led business...
Primary vs Secondary Data
Tracking Studies, Syndicated Studies
A thorough and agile tracking study can aid marketers to envision emerging trends, consumer...
Planning a Tracking Study: Aligning Marketing and Market Research Teams
Market Research Industry, Tracking Studies
In an increasingly competitive landscape, pharmaceutical companies are required to assess the...
Patient Insights from AplusA’s Multiple Myeloma Tracker
hemato-oncology, Tracking Studies, Syndicated Studies, Oncology
A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...
Multiple Myeloma Market Dynamics Revealed by AplusA Tracker
hemato-oncology, Tracking Studies, Syndicated Studies, Oncology